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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
11.05.2020 Coagulation 
abnormalities 
and thrombosis 
in patients with 
COVID-19 
The Lancet 
Haematology 
Comment 
 Many patients with severe COVID-
19 present with coagulation 
abnormalities that mimic other 
systemic coagulopathies 
associated with severe infections. 
 Coagulopathy in patients with 
COVID-19 is associated with an 
increased risk of death. 
 Potential therapeutic interventions 
are suggested. 
11.5.20 Organ 
procurement 
and 
transplantation 
during the 
COVID-19 
pandemic 
The Lancet 
Correspondence 
 Health-care providers, institutions, 
and patients are concerned about 
the potential effect that COVID-19 
will have on organ donation and 
transplantation. 
 Transplant recipients might have 
greater susceptibility to infection 
and increased viral burden. 
 Hospitals may not have the 
resources in terms of staff and 
equipment to care for recipients 
after transplantation. 
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Gender 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
May 2020 COVID-19 
Series: 
Gender 
Maintains | 
rapid literature 
review 
 Rapid literature review on how a health 
crisis such as an epidemic has adverse 
implications for gender and especially 
women 
 Includes recommendations for 
designing and implementing 
interventions in response to C19 
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
11.05.2020 Short-term forecasts 
of healthcare 
demand for 
countries in the early 
stage of COVID-19 
epidemics 
MRC Centre 
for Global 
Infectious 
Disease 
Analysis, 
Imperial 
College 
London 
Short-term forecasts of healthcare 
demand for low- & middle-income 
countries showing: 
 Number of #COVID19 infections 
 Expected number of deaths next 
14 days 
 Number of people requiring 
critical care 
 Impact of policy change 
11.05.2020 WHO statement: 
Tobacco use and 
COVID-19 
WHO | 
Statement 
 A review of studies by public 
health experts convened by WHO 
on 29 April 2020 found that 
smokers are more likely to 
develop severe disease with 
COVID-19 compared to non-
smokers 
 But WHO urges caution about 
amplifying unproven claims that 
tobacco or nicotine could reduce 
the risk of COVID-19 
May 2020 Enabling the private 
health sector in the 
national response to 
COVID-19: six 
current policy 
challenges 
Barbara 
O’Hanlon & 
Mark Hellowell 
(Commission 
by WHO) 
 Analysis of the policy challenges 
foundational for the technical 
documents that will be produced 
to support member states on how 
to implement the Engaging the 
private health delivery sector in 
the response to COVID-19 plan of 
action 
3 
30.03.2020 Engaging the private 
health delivery 
sector in the 
response to the 
COVID-19: A Plan of 
Action  
WHO | Interim 
guidance 
 Guidance to help governments 
with their efforts to engage the 
private sector as part of a whole-
of-society response to the 
pandemic and to maintain 
essential health services 
10.05.2020 Considerations for 
public health and 
social measures in 
the workplace in the 
context of COVID-19 
WHO 
 Annex to Considerations in 
adjusting public health and social 
measures in the workplace in the 
context of COVID-19 
10.05.2020 Considerations for 
school-related public 
health measures in 
the context of 
COVID-19 
WHO 
 Annex to Considerations for 
school-related public health and 
social measures in the context of 
COVID-19 
May 2020 Interim Guidance: 
Public health and 
social measures for 
COVID-19 
preparedness and 
response in low 
capacity and 
humanitarian 
settings version 1 
ICRC, IFRC, 
IOM, NRC, 
UNICEF, UN-
HABITAT, 
UNHCR, WHO 
in consultation 
with IASC 
members 
 This interim guidance outlines 
how to adapt to COVID-19 
prevention and response 
measures for use in low capacity 
and humanitarian settings 
07.05.2020 Global Humanitarian 
Response Plan for 
COVID-19: May 
Update 
UN OCHA 
 The humanitarian system is 
preparing for a sharp rise in 
conflict, food insecurity and 
poverty as a result of the C19 
pandemic 
 An increase in measles, malaria, 
cholera and other diseases are 
expected as vaccination 
programmes are put on hold, 
weak health systems are unable 
to cope and  supply chains are 
disrupted 
 The updated $6.7 billion global 
HRP is based on extensive in-
country consultations and reflects 
real-time needs 
 It brings together appeals from 
WHO and other UN humanitarian 
agencies shaped by NGOs and 
NGO consortia, through which 
4 
they can access funding through 
it 
 The Plan provides help and 
protection that prioritise the most 
vulnerable in society in 63 LMICs 
and includes programmes that 
respond to the projected rapid 
growth in food insecurity 
05.05.2020 Community-based 
health care, including 
outreach and 
campaigns, in the 
context of the 
COVID-19 pandemic 
WHO & 
UNICEF | 
Interim 
Guidance 
 Discusses the specific role of 
community-based healthcare in 
the pandemic context and 
outlines adaptations needed to 
keep people safe, maintain 
continuity of essential services 
and ensure an effective response 
to C19 
May 2020 COVID-19: What are 
prisons a particular 
risk, and what can be 
done to mitigate this? 
SSHAP | Brief 
 Includes practical considerations 
to mitigate risks associated with 
an outbreak of C19 in prisons in 
LMICs 
April 2020 Considerations and 
principles for 
shielding people at 
high risk of severe 
outcomes from 
COVID-19 
SSHAP | Brief 
 Considers the rationale for 
shielding individuals at high risk of 
severe disease or death from C19 
in LMICs 
 Provides overview of approaches 
to shielding, including who to 
shield, and the likely challenges 
and ways to mitigate these 
challengeslancet 
05.05.2020 LSHTM COVID-19 
Transmission Model 
(version 1) 
CMMID 
Repository 
 Simulate C19 epidemics in 152 
countries, and see how school 
closures, social distancing, 
elderly shielding, self-isolation 
and lockdowns may impact 
cases, hospitalisations and 
deaths. Designed for educational 
purposes not medical or policy 
advice. 
04.05.2020 Community 
participation is 
crucial in a pandemic 
The Lancet | 
Comment 
 Includes a panel of steps to 
community participation in the 
C19 response 
01.05.2020 Statement on the 
third meeting of the 
International Health 
Regulations (2005) 
Emergency 
Committee regarding 
the outbreak of 
WHO | 
Statement 
 Statement from the third meeting 
(teleconference) of the expanded 
Emergency Committee on 30 
April 2020 convened by the WHO 
DG under the IHR (2005) 
regarding CoVID-19 
5 
coronavirus disease 
(COVID-19) 
30.04.2020 COVID-19 and the 
Rights of Persons 
with Disabilities: 
Guidance 
UN Human 
Rights 
  
28.04.2020 COVI-PREG CHUV 
 International COVID-19 and 
Pregnancy   Registry 
28.04.2020 Accessibility 
Campaign – COVID-
19 
International 
Disability 
Alliance 
 Call for PH information and 
communications around COVID-
19 to be fully accessible 
24.04.2020 Handwashing 
compendium for low 
resource settings: a 
living document 
(edition 1) 
IDS Sanitation 
Learning Hub 
  
23.04.2020 Practical 
recommendations for 
the management of 
diabetes in patients 
with COVID-19 
The Lancet 
Diabetes & 
Endocrinology 
| Personal view 
 Practical recommendations for 
the management of diabetes in 
patients with C19, authored by an 
internal panel of experts in the 
fields of diabetes and 
endocrinology 
Ongoing WHO Country & 
Technical Guidance 
WHO   
Ongoing Rapid guidelines and 
evidence summaries 
NICE   
Ongoing Inter-Agency 
Standing Committee 
(IASC) 
IASC   
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Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
08.05.2020 Coronavirus blood-clot mystery 
intensifies 
Nature  |News Cassandra 
Willyard 
07.04.2020 All hands on deck: mobilising the 
private sector for the COVID-19 
response 
UHC2030 | Blog David Clarke, Mark 
Hellowell, Barbara 
O’Hanlon & 
Cynthia Eldridge 
07.05.2020 The Equity Gap – the need for a 
gendered response to the COVID-19 
crisis 
Maintains | blog   
07.05.2020 Strengthening water security for 
pandemic preparedness 
IDS | Opinion Rachel Cooper 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence 
& policy 
maps 
Current 
research 
including 
trials 
  Diagnosti
cs 
  Treatmen
ts 
  Vaccin
es 
WHO 
sitreps 
WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-
CoV-2 Test 
Tracker 
  Global 
COVID-19 
Clinical 
Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Argumen
ts 
Indonesi
a 
EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-
CoV-2 
Diagnostics
: 
performanc
e data 
  US NIH 
registered 
clinical 
trials 
Vaccine 
Centre 
LSHTM 
7 
Johns 
Hopkins 
University 
Europea
n CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
  
WEF 
  Sierra 
Leone 
 Oxford 
C19 
Governme
nt 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: 
C19 
Testing 
  COVID-
19 
Therapeuti
cs 
Accelerator 
  
Our World 
in Data 
  Singapor
e 
 Our 
World in 
Data: C19 
Policy 
responses 
COVID-
evidence 
      
Global 
5050 
  UK   Cochrane       
CEBM, 
University 
of Oxford 
  US   Clinicaltrials.g
ov 
      
Humanitari
an Data 
Exchange 
       UKCDR       
Information 
is Beautiful 
              
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
8 
C19 Resource Hubs 
Global  Region
al & 
Countr
y 
Academi
c 
journals 
& 
Publishe
rs 
Global Health 
Institutes/Centres/Funders/
Other 
Health 
Topics 
  Social 
Sciences 
WHO 
COVID-19 
pandemic  
Africa 
CDC 
The 
Lancet 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communicati
on 
African 
Union 
NEJM LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Elsevier ICL MRC Centre for Global 
Infectious Disease Analysis  
Global 
Menstrual 
Collective  
  Disability 
and 
inclusion 
WHO Global 
research 
GeoPoll
: SSA 
BMJ ODI SLH: 
Handwashi
ng in low 
resource 
settings 
  Coregrou
p IDDC 
COVID-19 
Solidarity 
Response 
Fund 
Global 
Health 
Networ
k Africa 
Cell 
Press 
Johns Hopkins University 
 
  Rings 
HSG 
Resyst 
Reach 
Wellcome 
UN African 
Acade
my of 
Science
s 
Cochran
e 
resource
s 
Center for Global 
Development 
    Social 
Developme
nt Direct 
C19 blog 
series 
UN Women Africa 
Evidenc
e 
PLoS CMMID Repository     
9 
Networ
k 
UNOCHA   Annals of 
Internal 
Medicine 
Norwegian Institute of Public 
Health 
    
UNHCR     Oxford Centre for Evidence-
based Medicine 
    
UNICEF      HEART     
UNESCO   Wiley 
Health 
Economi
cs 
 UKRI     
UN WFP   Pre-
prints 
medRxiv 
and 
bioRxiv 
 Evidence Aid     
GOARN           
EPI-WIN           
World Bank           
Our World in 
Data 
          
COVID-19 
Narratives by 
David 
Nabarro 
          
Reliefweb           
Humanitarian 
OpenStreetM
ap Team 
          
10 
Global 
Partnership 
for 
Sustainable 
Development 
Data 
          
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global 
Impact Study 
    
  
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
11.5.2020 COVID-19 Contact 
Tracing course 
Online learning 5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
11 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online learning 3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online learning Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel 
Coronavirus 
Online learning 3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online learning 3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online learning 5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online learning Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
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